Insulin glargine (Lantus), a new long-acting insulin.
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013810:Therapeutic Equivalency
D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine